150 related articles for article (PubMed ID: 12764368)
1. Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR.
González D; González M; Alonso ME; López-Pérez R; Balanzategui A; Chillón MC; Silva M; García-Sanz R; San Miguel JF
Leukemia; 2003 Jun; 17(6):1051-7. PubMed ID: 12764368
[TBL] [Abstract][Full Text] [Related]
2. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications.
González D; Balanzategui A; García-Sanz R; Gutiérrez N; Seabra C; van Dongen JJ; González M; San Miguel JF
Leukemia; 2003 Jul; 17(7):1398-403. PubMed ID: 12835730
[TBL] [Abstract][Full Text] [Related]
3. Incomplete DJH rearrangements.
González D; Garcia-Sanz R
Methods Mol Med; 2005; 113():165-73. PubMed ID: 15968101
[TBL] [Abstract][Full Text] [Related]
4. Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.
González D; González M; Balanzategui A; Sarasquete ME; López-Pérez R; Chillón MC; García-Sanz R; San Miguel JF
Haematologica; 2005 Jul; 90(7):906-13. PubMed ID: 15996928
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
[TBL] [Abstract][Full Text] [Related]
6. Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma.
Martinez-Lopez J; Martinez-Sanchez P; Garcia-Sanz R; Sarasquete ME; Ayala R; Gonzalez M; Bautista JM; Gonzalez D; San Miguel J; Garcia-Effron G; Lahuerta JJ
J Mol Diagn; 2006 Jul; 8(3):364-70. PubMed ID: 16825510
[TBL] [Abstract][Full Text] [Related]
7. Use of UITma DNA polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions.
Linke B; Bolz I; Pott C; Hiddemann W; Kneba M
Leukemia; 1995 Dec; 9(12):2133-7. PubMed ID: 8609729
[TBL] [Abstract][Full Text] [Related]
8. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies.
Aubin J; Davi F; Nguyen-Salomon F; Leboeuf D; Debert C; Taher M; Valensi F; Canioni D; Brousse N; Varet B
Leukemia; 1995 Mar; 9(3):471-9. PubMed ID: 7533868
[TBL] [Abstract][Full Text] [Related]
9. The use of fluorescent molecular beacons in real time PCR of IgH gene rearrangements for quantitative evaluation of multiple myeloma.
Martínez-López J; Lahuerta JJ; Salama P; Ayala R; Bautista JM
Clin Lab Haematol; 2004 Feb; 26(1):31-5. PubMed ID: 14738435
[TBL] [Abstract][Full Text] [Related]
10. Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin's lymphomas with high rates of somatic hypermutation.
Catherwood MA; Gonzalez D; Patton C; Dobbin E; Venkatraman L; Alexander HD
J Clin Pathol; 2007 May; 60(5):524-8. PubMed ID: 16816169
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases.
Hadzidimitriou A; Stamatopoulos K; Belessi C; Lalayianni C; Stavroyianni N; Smilevska T; Hatzi K; Laoutaris N; Anagnostopoulos A; Kollia P; Fassas A
Haematologica; 2006 Jun; 91(6):781-7. PubMed ID: 16769580
[TBL] [Abstract][Full Text] [Related]
12. Improvement of clonality detection rate in multiple myeloma using fluorescent IgH PCR with different sets of primers.
Welterlin V; Debecker A; Tschieb D; Zanetti C; Lange W; Hénon PR
J Hematother Stem Cell Res; 2000 Dec; 9(6):983-91. PubMed ID: 11177613
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
Kara IO; Duman BB; Afsar CU
J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
[TBL] [Abstract][Full Text] [Related]
14. Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma.
Ladetto M; Donovan JW; Harig S; Trojan A; Poor C; Schlossnan R; Anderson KC; Gribben JG
Biol Blood Marrow Transplant; 2000; 6(3):241-53. PubMed ID: 10871149
[TBL] [Abstract][Full Text] [Related]
15. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
[TBL] [Abstract][Full Text] [Related]
16. Relative quantification of residual tumor cells by lightcycler real-time IgH PCR in autografted multiple myeloma patients.
Rimelen V; Ferrand C; Debecker A; Sovalat H; Tancredi C; Eidenschenk A; Hénon P
Leukemia; 2005 Mar; 19(3):492-5. PubMed ID: 15625553
[No Abstract] [Full Text] [Related]
17. Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards.
Gerard CJ; Olsson K; Ramanathan R; Reading C; Hanania EG
Cancer Res; 1998 Sep; 58(17):3957-64. PubMed ID: 9731509
[TBL] [Abstract][Full Text] [Related]
18. Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma.
García-Sanz R; López-Pérez R; Langerak AW; González D; Chillón MC; Balanzategui A; Mateos MV; Alaejos I; González M; Van Dongen JJ; San Miguel JF
Haematologica; 1999 Apr; 84(4):328-35. PubMed ID: 10190947
[TBL] [Abstract][Full Text] [Related]
19. Identification of monoclonal B-cell populations by rapid cycle polymerase chain reaction. A practical screening method for the detection of immunoglobulin gene rearrangements.
Segal GH; Wittwer CT; Fishleder AJ; Stoler MH; Tubbs RR; Kjeldsberg CR
Am J Pathol; 1992 Dec; 141(6):1291-7. PubMed ID: 1466395
[TBL] [Abstract][Full Text] [Related]
20. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
